Enough with the Consensus Already!
08.06.2020
In theory, politicians and doctors who have studied for a long time are scientists. But in practice, few have a scientific approach.
World
Security and privacy experts sound the alarm on contact tracing apps
27.05.2020
The terrorist acts of September 11, 2001 became the starting point for massive surveillance of the world's citizens, and not least in Western countries such as the United States and the United Kingdom.
Facebook scrubs content related to Generation Identity
11.05.2020
According to information obtained by a French publication, any content supporting, representing or praising the anti-immigration movement is deleted by the social network.
How to think post-Planet Lockdown
01.05.2020
Between unaccountability of elites and total fragmentation of civil society, Covid-19 as a circuit breaker is showing how the king – systemic design – is naked.
An Analysis of COVID-19 and its Social, Political, Economic, and Psychological Toll on America and the World
01.05.2020
To begin with, I must state the projected fact that all major powers, US, China, EU as a whole, and Russia will come out bruised and battered by this Coronavirus, aka COVID-19, and quite possibly its second strain C
How long does the Coronavirus generally survive?
28.04.2020
An Italian study has analyzed Covid's ability to resist and survive with respect to temperature: 24 hours at 37° C, much longer if it drops to 20° C.
Coronavirus Is a Boon for Sea Turtles
22.04.2020
Researchers are seeing an increase in nests as restrictions keep humans and harmful waste off beaches
The Overpopulation Myth
21.04.2020
The Coronavirus Panic: Pure Waste or Midwife of Progress?
20.04.2020
I will not speculate on what has driven so many governments to shut their countries down for at least a month. Doubtless, the truth will finally emerge. But that may be next year, or the year after.
Gilead Sciences stock soars after it touts Remdesivir trial results
17.04.2020
An announcement this week by the US pharmaceutical company specializing in virus research and medicine, Gilead Sciences, caused a three percent jump in the S&P 500 index after the market closed, while the company's own shares moved up 15
